Hippocampal Dose From Stereotactic Radiosurgery for 4 to 10 Brain Metastases: Risk Factors and Feasibility of Dose Reduction Via Reoptimization.
Publication
, Journal Article
Birer, SR; Olson, AC; Adamson, J; Kim, GJ; Salama, JK; Kirkpatrick, JP
Published in: Int J Radiat Oncol Biol Phys
October 1, 2016
Duke Scholars
Published In
Int J Radiat Oncol Biol Phys
DOI
EISSN
1879-355X
Publication Date
October 1, 2016
Volume
96
Issue
2S
Start / End Page
E608 / E609
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Birer, S. R., Olson, A. C., Adamson, J., Kim, G. J., Salama, J. K., & Kirkpatrick, J. P. (2016). Hippocampal Dose From Stereotactic Radiosurgery for 4 to 10 Brain Metastases: Risk Factors and Feasibility of Dose Reduction Via Reoptimization. Int J Radiat Oncol Biol Phys, 96(2S), E608–E609. https://doi.org/10.1016/j.ijrobp.2016.06.2153
Birer, S. R., A. C. Olson, J. Adamson, G. J. Kim, J. K. Salama, and J. P. Kirkpatrick. “Hippocampal Dose From Stereotactic Radiosurgery for 4 to 10 Brain Metastases: Risk Factors and Feasibility of Dose Reduction Via Reoptimization.” Int J Radiat Oncol Biol Phys 96, no. 2S (October 1, 2016): E608–9. https://doi.org/10.1016/j.ijrobp.2016.06.2153.
Birer SR, Olson AC, Adamson J, Kim GJ, Salama JK, Kirkpatrick JP. Hippocampal Dose From Stereotactic Radiosurgery for 4 to 10 Brain Metastases: Risk Factors and Feasibility of Dose Reduction Via Reoptimization. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E608–9.
Birer, S. R., et al. “Hippocampal Dose From Stereotactic Radiosurgery for 4 to 10 Brain Metastases: Risk Factors and Feasibility of Dose Reduction Via Reoptimization.” Int J Radiat Oncol Biol Phys, vol. 96, no. 2S, Oct. 2016, pp. E608–09. Pubmed, doi:10.1016/j.ijrobp.2016.06.2153.
Birer SR, Olson AC, Adamson J, Kim GJ, Salama JK, Kirkpatrick JP. Hippocampal Dose From Stereotactic Radiosurgery for 4 to 10 Brain Metastases: Risk Factors and Feasibility of Dose Reduction Via Reoptimization. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E608–E609.
Published In
Int J Radiat Oncol Biol Phys
DOI
EISSN
1879-355X
Publication Date
October 1, 2016
Volume
96
Issue
2S
Start / End Page
E608 / E609
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences